Evan Tzanis
Chief Operating Officer at Neuraptive Therapeutics, Inc.
Evan Tzanis active positions
| Companies | Position | Start | End |
|---|---|---|---|
Neuraptive Therapeutics, Inc.
 Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | Chief Operating Officer | 2022-10-23 | - |
| Chief Tech/Sci/R&D Officer | 2018-12-31 | 2022-10-23 |
Career history of Evan Tzanis
Former positions of Evan Tzanis
| Companies | Position | Start | End |
|---|---|---|---|
Endo Pharmaceuticals, Inc.
 Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Corporate Officer/Principal | 2014-05-31 | 2014-07-31 |
| PARATEK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 2014-08-31 | - |
Statistics
International
| United States | 4 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Operating Officer | 1 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoral
| Health Technology | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| PARATEK PHARMACEUTICALS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Endo Pharmaceuticals, Inc.
Endo Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Endo Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. The company provides research and development of generic pharmaceutical products for controlling pain. Its product includes Lidoderm, Percocet, Percodan, Frova, DepoDur, and Zydone. The company is headquartered in Malvern, PA. | Health Technology |
Neuraptive Therapeutics, Inc.
Neuraptive Therapeutics, Inc. BiotechnologyHealth Technology Neuraptive Therapeutics, Inc. engages in developing therapeutic technology for the acute surgical repair of injured peripheral nerves. Its products include AxoFuse, AxoTrim, and AxoBond. The company was founded by David Jackson in 2016 and is headquartered in Lafayette, Co. | Health Technology |
- Stock Market
- Insiders
- Evan Tzanis
- Experience
